A cloud-based digital health navigation program for colorectal cancer screening
基于云的结直肠癌筛查数字健康导航程序
基本信息
- 批准号:10697474
- 负责人:
- 金额:$ 39.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAdvisory CommitteesAgeAmericanCOVID-19Cancer EtiologyCaringCessation of lifeColonoscopyColorectal CancerCommunitiesCost AnalysisDevicesEffectivenessElectronicsEligibility DeterminationEnsureEnvironmentEthnic PopulationFecesFederally Qualified Health CenterFeedbackFocus GroupsFutureGoalsHealth TechnologyHealth systemHealthcare SystemsHomeKnowledgeLearningMedicalModelingOutcomePatientsPhasePopulation HeterogeneityPreventive carePreventive servicePublicationsRaceRandomized, Controlled TrialsReportingRiskRuralScheduleSiteSmall Business Technology Transfer ResearchSourceStreamSubgroupTabletsTechnologyTestingTextText MessagingTimeTrainingUnited StatesUnited States Preventative Services Task ForceUniversitiesUpdateVisitWorkaccountable care organizationagedbarrier to carecloud basedcolorectal cancer screeningcommercializationcostdigitaldigital healtheffectiveness testingempowermentforesthealth care service organizationhealth care settingshealth disparityinnovationmedical schoolsmemberoutreachpatient portalpilot trialprimary care practiceprimary outcomeprogramsresponsescreeningscreening guidelinesscreening servicessecondary analysisuptakeusabilityweb app
项目摘要
Over 30% of age-eligible Americans fail to receive recommended screening for colorectal cancer (CRC), the
second leading cause of cancer death in the United States. Multilevel barriers explain why so many Americans
fail to receive routine CRC screening. Patients report a lack of knowledge about the need for screening or their
screening options, and many view screening as messy, uncomfortable, or embarrassing. Busy clinicians report
a lack of time to deliver preventive care, and many clinicians only discuss colonoscopy. Lastly, healthcare
systems lack strategies to reach out to patients independent of a scheduled medical visit. Disruptions caused
by COVID19 also have led to a decrease in the use of preventive services. To address these multilevel
barriers, our team has developed and tested a tablet-based digital health navigator for colorectal cancer
screening called mPATH™ (mobile Patient Technology for Health). mPATH™ determines if patients are due
for CRC screening, educates them about their options, and lets them request a screening test directly via the
program. In a randomized controlled trial conducted in primary care practices, mPATH™ doubled the
proportion of patients who completed CRC screening and had excellent usability ratings. However, we have
learned that our tablet-based model of mPATH™ is difficult to scale as it requires on-site training and changes
to workflows. The goal of this Fast Track STTR proposal is to develop and test a cloud-based version of
mPATH™ that patients can use at home independent of a scheduled medical visit. Patients will access
mPATH™ on their own devices using a hyperlink sent via text message or patient portal. The cloud version of
mPATH™ will have the proven effective content of the tablet version, including the ability to request a
screening test directly via the program. mPATH™ will then share this information with the patient’s healthcare
organization so screening can be arranged. This cloud-based version will be highly scalable, have broad
reach, and be easy to support, making it a commercially viable product. To accomplish this goal, the work of
this proposal will: (1) create a culturally appropriate and engaging cloud-based version of mPATH™ by
leveraging input from community members, an expert Scientific Advisory Committee, and feedback from users;
(2) determine the feasibility of the cloud-based mPATH™-CRC web app in a highly pragmatic pilot trial
conducted in a large health system; (3) test the reach and effectiveness of the mPATH™ web app in two
different healthcare settings: a large health system, and an Accountable Care Organization that includes rural
Federally Qualified Health Centers; and (4) determine the value generated by mPATH™ in each healthcare
setting. This Fast Track STTR will provide information that is critical to mPATH™’s future commercialization by
demonstrating its reach into diverse populations, its effectiveness in increasing screening, and the value it
generates to potential future customers. If successful, mPATH™ will fill a critical need for a commercially
available, easily scalable solution for colorectal cancer screening and potentially other preventive services.
超过30%的符合年龄的美国人没有接受推荐的结肠直肠癌(CRC)筛查,
是美国癌症死亡的第二大原因。多层次的障碍解释了为什么这么多美国人
未能接受常规CRC筛查。患者报告缺乏对筛查的必要性或其
筛选选项,许多人认为筛选是混乱的,不舒服的,或尴尬的。忙碌的临床医生报告说
缺乏提供预防性护理的时间,许多临床医生只讨论结肠镜检查。最后,医疗保健
系统缺乏独立于排定的医疗访问而接触患者的策略。造成中断
COVID 19也导致预防服务的使用减少。为了解决这些多层次的
我们的团队开发并测试了一种基于平板电脑的结直肠癌数字健康导航仪,
mPATH™(移动的患者健康技术)。mPATH™确定患者是否应
对于CRC筛查,教育他们关于他们的选择,并让他们直接通过
程序.在一项在初级保健实践中进行的随机对照试验中,mPATH™使
完成CRC筛选并具有优秀可用性评级的患者比例。但我们
我了解到,我们基于平板电脑的mPATH™模型很难扩展,因为它需要现场培训和更改
到工作流。此Fast Track STTR提案的目标是开发和测试基于云的
mPATH™,患者可以在家中使用,而无需定期就诊。患者将获得
使用通过文本消息或患者门户发送的超链接在他们自己的设备上使用mPATH™。云版本的
mPATH™将拥有平板电脑版本的经验证的有效内容,包括请求
直接通过程序进行筛选测试。然后,mPATH™将与患者的医疗保健部门共享此信息
组织,以便安排筛选。这个基于云的版本将具有高度可扩展性,
到达,并易于支持,使其成为商业上可行的产品。为了实现这一目标,
该提案将:(1)通过以下方式创建一个文化上合适的、基于云的mPATH™版本
利用社区成员的投入、专家科学咨询委员会和用户的反馈;
(2)确定基于云的mPATH™-CRC Web应用程序在高度实用的试点试验中的可行性
在大型卫生系统中进行;(3)在两个方面测试mPATH™ Web应用程序的覆盖范围和有效性
不同的医疗保健环境:一个大型的卫生系统和一个责任医疗组织,包括农村
联邦合格的卫生中心;以及(4)确定mPATH™在每个医疗保健中产生的价值
设置.此快速通道STTR将提供对mPATH™未来商业化至关重要的信息,
展示了它对不同人群的影响,它在增加筛查方面的有效性,以及它的价值。
为潜在的未来客户提供服务。如果成功,mPATH™将满足商业上的关键需求。
为结直肠癌筛查和潜在的其他预防服务提供可用的、易于扩展的解决方案。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David P Miller其他文献
Color Doppler and two-dimensional echocardiographic determination of the mechanism of aortic regurgitation with surgical correlation.
彩色多普勒和二维超声心动图测定主动脉瓣关闭不全的机制与手术的相关性。
- DOI:
- 发表时间:
1996 - 期刊:
- 影响因子:6.5
- 作者:
G. Cohen;Carol I. Duffy;Allan L. Klein;David P Miller;D. Cosgrove;W. Stewart - 通讯作者:
W. Stewart
Long‐Term Protection from Myocardial Ischemic Events in a Randomized Trial of Brief Integrin β3 Blockade with Percutaneous Coronary Intervention
经皮冠状动脉介入治疗短暂整合素 β3 阻断的随机试验对心肌缺血事件的长期保护
- DOI:
10.1097/00132586-199808000-00009 - 发表时间:
1998 - 期刊:
- 影响因子:0
- 作者:
E. Topol;J. Ferguson;H. Weisman;J. Tcheng;S. Ellis;N. Kleiman;R. Ivanhoe;Ann L. Wang;David P Miller;K. Anderson;R. Califf - 通讯作者:
R. Califf
Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. EPIC and EPILOG Investigators. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation of PTCA To Improve Long-term Outcome with abciximab GPIIb/IIIa Receptor Block
阿昔单抗对血管成形术并发症的减少很大程度上与基线病变形态无关。
- DOI:
10.1016/s0735-1097(98)00403-3 - 发表时间:
1998 - 期刊:
- 影响因子:24
- 作者:
Stephen G. Ellis;A. Lincoff;David P Miller;J. Tcheng;N. Kleiman;D. Kereiakes;R. Califf;E. Topol - 通讯作者:
E. Topol
Benefit of early sustained reperfusion in patients with prior myocardial infarction (the GUSTO-I trial). Global Utilization of Streptokinase and TPA for occluded arteries.
早期持续再灌注对既往心肌梗塞患者的益处(GUSTO-I 试验)。
- DOI:
- 发表时间:
1998 - 期刊:
- 影响因子:2.8
- 作者:
D. Brieger;K. Mak;H. White;N. Kleiman;David P Miller;A. Vahanian;A. Ross;R. Califf;E. Topol - 通讯作者:
E. Topol
Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication.
在一项短期整合素 β3 阻断联合经皮冠状动脉介入治疗的随机试验中,可长期预防心肌缺血事件。
- DOI:
- 发表时间:
1997 - 期刊:
- 影响因子:0
- 作者:
E. Topol;J. Ferguson;H. Weisman;J. Tcheng;Stephen G. Ellis;N. Kleiman;R. Ivanhoe;Ann L. Wang;David P Miller;K. Anderson;R. Califf - 通讯作者:
R. Califf
David P Miller的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David P Miller', 18)}}的其他基金
Effectiveness and Implementation of mPATH-CRC: a Mobile Health System for Colorectal Cancer Screening
mPATH-CRC 的有效性和实施:用于结直肠癌筛查的移动医疗系统
- 批准号:
10165873 - 财政年份:2020
- 资助金额:
$ 39.8万 - 项目类别:
A Personalized Digital Outreach Intervention for Lung Cancer Screening
肺癌筛查的个性化数字外展干预措施
- 批准号:
10551856 - 财政年份:2020
- 资助金额:
$ 39.8万 - 项目类别:
A Personalized Digital Outreach Intervention for Lung Cancer Screening
肺癌筛查的个性化数字外展干预措施
- 批准号:
10318171 - 财政年份:2020
- 资助金额:
$ 39.8万 - 项目类别:
A Personalized Digital Outreach Intervention for Lung Cancer Screening
肺癌筛查的个性化数字外展干预措施
- 批准号:
10062917 - 财政年份:2020
- 资助金额:
$ 39.8万 - 项目类别:
A Personalized Digital Outreach Intervention for Lung Cancer Screening
肺癌筛查的个性化数字外展干预措施
- 批准号:
9885242 - 财政年份:2020
- 资助金额:
$ 39.8万 - 项目类别:
Effectiveness and Implementation of mPATH-CRC: a Mobile Health System for Colorectal Cancer Screening
mPATH-CRC 的有效性和实施:用于结直肠癌筛查的移动医疗系统
- 批准号:
9895633 - 财政年份:2018
- 资助金额:
$ 39.8万 - 项目类别:
Effectiveness and Implementation of mPATH-CRC: a Mobile Health System for Colorectal Cancer Screening
mPATH-CRC 的有效性和实施:用于结直肠癌筛查的移动医疗系统
- 批准号:
10116309 - 财政年份:2018
- 资助金额:
$ 39.8万 - 项目类别:
Effectiveness and Implementation of mPATH-CRC: a Mobile Health System for Colorectal Cancer Screening
mPATH-CRC 的有效性和实施:用于结直肠癌筛查的移动医疗系统
- 批准号:
10382400 - 财政年份:2018
- 资助金额:
$ 39.8万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 39.8万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 39.8万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 39.8万 - 项目类别:
Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 39.8万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 39.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 39.8万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 39.8万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 39.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 39.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 39.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




